Ph-sensitive and bioreducible polymer-virus complex for cancer treatment
AssigneeGenemedicine Co., Ltd.
InventorsChae Ok YUN, Dayananda KASALA
Life of this patent
Estimating the term…
Loading patent…
AssigneeGenemedicine Co., Ltd.
InventorsChae Ok YUN, Dayananda KASALA
Estimating the term…
Disclosed is a pH-sensitive and bioreducible polymer-virus complex which can destroy tumor cells more effectively by increasing the efficiency of virus transduction. A pH-sensitive and bioreducible polymer contains (i) an escapable portion from immune reactions, (ii) a chargeable portion having one or more amine groups and (iii) a bioreducible portion including one or more disulfide linkages. The and to a pharmaceutical composition containing the polymer-virus complex. Also disclosed are a pharmaceutical composition containing the pH-sensitive and bioreducible polymer-virus complex and methods for treating cancer in a subject, employing the composition.
A method for treating cancer in a subject in need thereof, comprising a step of administering a pharmaceutical composition comprising (a) a therapeutically effective amount of a polymer-virus complex and (b) a pharmaceutically acceptable carrier to the subject,
A method for treating a solid tumor in a subject in need thereof, comprising a step of administering a pharmaceutical composition comprising (a) a therapeutically effective amount of a polymer-virus complex and (b) a pharmaceutically acceptable carrier to the subject,
Dependencies are inferred from the claim text.